Table 1.
Effect of treatment with the probiotic on the serum levels of IL-1β at different times and across all study groups.
| Groups | IL-1ß0 (pg/mL) | IL-1ß15 (pg/mL) | IL-1ß30 (pg/mL) | P value |
|---|---|---|---|---|
| 1 (acrylamide) | 57.88 ± 5.88 | 70.39 ± 25.59 | 45.14 ± 6.52 | 0.51a, 0.275b, 0.51c |
| 2 (acrylamide + LD) | 60.04 ± 6.51 | 72.92 ± 12.53 | 26.06 ± 2.66 | 0.275a, 0.05b, 0.05c |
| 3 (acrylamide + HD) | 43.72 ± 4.56 | 37.50 ± 15.33 | 29.94 ± 3.65 | 0.513a, 0.05b, 0.82c |
| 4 (control) | 63.05 ± 7.17 | 70.42 ± 13.54 | 23.87 ± 4.01 | 0.82a, 0.05b, 0.05c |
| P value∗ | 0.94 | 0.46 | 0.03 | — |
Data are presented as mean ± SEM (standard error of the mean). LD: low dose of probiotics; HD: high dose of probiotics; bold P values show a significant difference (P < 0.05). aComparison between days 0 and 15 (t-test). bComparison between days 0 and 30 (t-test). cComparison between days 15 and 30 (t-test). ∗Comparison of 4 groups (one-way ANOVA).